Cancer Talk

News

Roswell Park Comprehensive Cancer Center, University of Pittsburgh Cancer Institute Receive Prestigious National Cancer Institute SPORE Grant for Ovarian Cancer Research

Announcement of the Roswell Park Cancer Institute (RPCI) and University of Pittsburgh Cancer Institute (UPCI), partner with University of Pittsburgh Medical Center (UPMC) Cancer Center, Specialized Program of Research Excellence (SPORE) in Ovarian Cancer award from the National Cancer Institute (NCI). The coveted grant will provide more than $11 million over 5 years.
News

Movie Screening to Benefit the Familial Ovarian Cancer Registry at Roswell Park

Western New Yorkers are invited to attend a special screening of the film Decoding Annie Parker on Thursday, Sept. 26, with partial proceeds benefitting the Familial Ovarian Cancer Registry at Roswell Park Cancer Institute (RPCI). The film’s director, Steven Bernstein, is a Buffalo native who will return to Western New York for the film’s screening prior to its nationwide release. Funds from the event will also support BRCA Gene Awareness Inc.

News

Researchers Identify Mechanisms that Oversee the Development of a Pro-Tumor Network

Researchers at RPCI have uncovered a new pathway by which cancer cells, such as in breast cancer, stimulate the expansion of myeloid-derived suppressor cells (MDSCs), a blood cell population known to interfere with the body’s anti-tumor response. The findings shed new light on the pathological events that fuel tumor growth and could lead to the development of new therapies to hinder it.
News

Roswell Park Comprehensive Cancer Center Appoints New Medical Director

Anthony L. Picone, MD, PhD, MBA, cardiothoracic surgeon in the Department of Thoracic Surgery, has been named medical director of Roswell Park Cancer Institute (RPCI). Dr. Picone has been employed at Roswell Park since April of 2009, and for the past six months has served as RPCI’s interim medical director.
News

Wanted: Cigarette Smokers to Participate in Roswell Park Study

How willing are smokers to try different tobacco products based on the price? Researchers at RPCI are asking that and other questions in a clinical study that examines the impact of price and other factors on the substitution of smokeless tobacco products for cigarettes. They're seeking 200 smokers who are willing to try new products and cut down on their smoking. The study will help to explain the motivation behind decisions about health and offer new insights on health-behavior change.
News

Adaptimmune Opens Phase I/IIa Clinical Trial in Ovarian Cancer at Roswell Park Comprehensive Cancer Center and City of Hope

Researchers at Adaptimmune, RPCI and City of Hope announced the opening of a Phase I/IIa clinical trial in ovarian cancer at RPCI and City of Hope. The team will investigate the safety, bioactivity and effectiveness of treating patients with their own T cells after genetically engineering the cells to enhance their antitumor properties.